IBC is committed to providing your patients with access to quality, cost-effective prescription medications through our prescription drug program, which is administered by FutureScripts^®, an independent pharmacy benefits manager. As part of this effort, ICORE Healthcare (ICORE), a leader in specialty pharmacy services, has been chosen as the exclusive specialty pharmacy provider within the FutureScripts specialty network.

Effective February 1, 2012, all prescription drug requests for commercial members submitted through the FutureScripts Direct Ship Specialty Pharmacy Program will be routed to ICORE for fulfillment.

Existing specialty prescriptions

If commercial members currently have prescriptions on file with another specialty pharmacy, they will be transferred to ICORE on or before February 1, 2012. These members will continue to have their specialty medications delivered to the location of their choice in the U.S., and this change will not affect their cost-sharing. Our prior authorization process will remain the same, so members with an existing authorization will not need to request a new one until the current authorization has expired.

Specialty services through ICORE

Through ICORE, members will receive convenient access to the following specialty services:

• Comprehensive coordination of care. This coordination of care includes benefits investigation, prior authorization coordination, and ongoing refill reminders.
• Direct access to pharmacists and nurses. The ICORE support staff is available toll-free to answer any questions that your IBC patients may have.
• Clinical programs. ICORE monitors patient progress to achieve optimal treatment outcomes.
• Educational materials. Patients have access to helpful materials, such as instruction guides to assist with self-administering medication.
• Free delivery. Medications are delivered at no cost to the patient?s home or another address in the U.S. in two to five business days from the date the order is received.
• Ancillary supplies. Items such as syringes and needles are available with the medication at no additional cost.

To enroll a member in the FutureScripts Direct Ship Specialty Pharmacy Program, please call FutureScripts at 1-888-678-7012 or visit www.futurescripts.com/priorauthorization and download the Direct Ship Injectables Form. If any of your IBC patients have questions about this transition, please have them call the telephone number listed on their ID card under pharmacy benefits.